![Nicholas Plummer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Plummer
Algemeen Adviseur bij
VOLITIONRX LIMITED
Vermogen: 54 369 $ op 31-05-2026
Profiel
Nicholas Plummer is currently Group General Counsel at VolitionRX Ltd. since 2021.
Former roles include Secretary & General Counsel at Ark Therapeutics Group Plc from 2004 to 2008, Secretary & General Counsel at Novacyt SAS, Managing Counsel-Europe at Patheon France SAS from 2013 to 2021, and a position at Ashurst Morris Crisp from 2004 to 2007.
Education includes graduation from The University of Reading.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VOLITIONRX LTD 0,24% | 17-03-2026 | 20.363 ( 0,24% ) | 54 369 $ | 31-05-2026 |
Actieve functies van Nicholas Plummer
| Bedrijven | Functie | Begin |
|---|---|---|
| VOLITIONRX LIMITED | Algemeen Adviseur | 01-11-2021 |
Eerdere bekende functies van Nicholas Plummer
| Bedrijven | Functie | Einde |
|---|---|---|
Patheon France SAS
 Patheon France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01-01-2021 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Algemeen Adviseur | 01-01-2008 |
| NOVACYT | Algemeen Adviseur | - |
Opleiding van Nicholas Plummer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Commercial Services |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacyt SAS
 Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases | Health Technology |
Patheon France SAS
Patheon France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
VolitionRX Ltd.
 VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
